HBT
ABBV icon

Heartland Bank & Trust’s AbbVie ABBV Stock Holding History

Heartland Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.72M Buy
21,721
+5,308
+32% +$1.18M 1.07% 21
2025
Q4 		$3.75M Sell
16,413
-204
-1% -$46.5K 1.59% 15
2025
Q3 		$3.85M Buy
16,617
+7,496
+82% +$1.53M 1.59% 14
2025
Q2 		$1.69M Sell
9,121
-163
-2% -$30.3K 0.79% 25
2025
Q1 		$1.95M Buy
9,284
+1,041
+13% +$202K 1% 21
2024
Q4 		$1.46M Sell
8,243
-337
-4% -$62K 0.8% 25
2024
Q3 		$1.69M Sell
8,580
-145
-2% -$27.1K 0.91% 18
2024
Q2 		$1.5M Buy
8,725
+2,421
+38% +$401K 0.85% 18
2024
Q1 		$1.15M Sell
6,304
-43
-0.7% -$7.41K 0.67% 29
2023
Q4 		$984K Buy
6,347
+224
+4% +$32.7K 0.68% 30
2023
Q3 		$913K Buy
6,123
+67
+1% +$9.84K 0.72% 32
2023
Q2 		$816K Buy
6,056
+410
+7% +$60.1K 0.64% 40
2023
Q1 		$900K Sell
5,646
-3,851
-41% -$589K 0.68% 39
2022
Q4 		$1.53M Sell
9,497
-502
-5% -$77K 1.13% 17
2022
Q3 		$1.34M Buy
9,999
+1,463
+17% +$210K 1.28% 16
2022
Q2 		$1.31M Buy
8,536
+93
+1% +$14.2K 1.16% 18
2022
Q1 		$1.37M Buy
8,443
+5,740
+212% +$834K 1.04% 17
2021
Q4 		$366K Buy
+2,703
New +$319K 0.27% 104

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Heartland Bank & Trust's ABBV Position: Q1 2026 in Review

Heartland Bank & Trust increased its AbbVie (ABBV) stake by 32% in Q1 2026, buying an estimated $1.18M and bringing the position to 21,721 shares worth $4.72M. The position accounts for 1.07% of the portfolio, ranked #21.

Heartland Bank & Trust first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Heartland Bank & Trust held 21,721 shares of AbbVie worth $4.72M as of Q1 2026.
  • Heartland Bank & Trust bought 5,308 AbbVie shares in Q1 2026, an estimated $1.18M.
  • AbbVie made up 1.07% of Heartland Bank & Trust's portfolio in Q1 2026, its #21 holding.
  • Heartland Bank & Trust first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Heartland Bank & Trust's 13F filing for Q1 2026, filed 6 May 2026.